366 related articles for article (PubMed ID: 18349289)
1. Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk.
Lankisch TO; Schulz C; Zwingers T; Erichsen TJ; Manns MP; Heinemann V; Strassburg CP
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):695-701. PubMed ID: 18349289
[TBL] [Abstract][Full Text] [Related]
2. Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatment.
Lankisch TO; Behrens G; Ehmer U; Möbius U; Rockstroh J; Wehmeier M; Kalthoff S; Freiberg N; Manns MP; Schmidt RE; Strassburg CP
J Hepatol; 2009 May; 50(5):1010-8. PubMed ID: 19303655
[TBL] [Abstract][Full Text] [Related]
3. Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype.
Lankisch TO; Moebius U; Wehmeier M; Behrens G; Manns MP; Schmidt RE; Strassburg CP
Hepatology; 2006 Nov; 44(5):1324-32. PubMed ID: 17058217
[TBL] [Abstract][Full Text] [Related]
4. Combined UGT1A1 and UGT1A7 variant alleles are associated with increased risk of Gilbert's syndrome in Taiwanese adults.
Teng HC; Huang MJ; Tang KS; Yang SS; Tseng CS; Huang CS
Clin Genet; 2007 Oct; 72(4):321-8. PubMed ID: 17850628
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of a functional TATA box polymorphism of the UDP glucuronosyltransferase 1A7 gene.
Lankisch TO; Vogel A; Eilermann S; Fiebeler A; Krone B; Barut A; Manns MP; Strassburg CP
Mol Pharmacol; 2005 May; 67(5):1732-9. PubMed ID: 15716465
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of the UDP-glucuronosyltransferase 1A7 gene and irinotecan toxicity in Japanese cancer patients.
Ando M; Ando Y; Sekido Y; Ando M; Shimokata K; Hasegawa Y
Jpn J Cancer Res; 2002 May; 93(5):591-7. PubMed ID: 12036456
[TBL] [Abstract][Full Text] [Related]
7. UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in Japan.
Hazama S; Mishima H; Tsunedomi R; Okuyama Y; Kato T; Takahashi K; Nozawa H; Ando H; Kobayashi M; Takemoto H; Nagata N; Kanekiyo S; Inoue Y; Hamamoto Y; Fujita Y; Hinoda Y; Okayama N; Oba K; Sakamoto J; Oka M
Cancer Sci; 2013 Dec; 104(12):1662-9. PubMed ID: 24033692
[TBL] [Abstract][Full Text] [Related]
8. Rapid allelic discrimination by TaqMan PCR for the detection of the Gilbert's syndrome marker UGT1A1*28.
Ehmer U; Lankisch TO; Erichsen TJ; Kalthoff S; Freiberg N; Wehmeier M; Manns MP; Strassburg CP
J Mol Diagn; 2008 Nov; 10(6):549-52. PubMed ID: 18832463
[TBL] [Abstract][Full Text] [Related]
9. Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: a molecular and clinical study of 75 patients.
Rouits E; Boisdron-Celle M; Dumont A; Guérin O; Morel A; Gamelin E
Clin Cancer Res; 2004 Aug; 10(15):5151-9. PubMed ID: 15297419
[TBL] [Abstract][Full Text] [Related]
10. The combination of new missense mutation with [A(TA)7TAA] dinucleotide repeat in UGT1A1 gene promoter causes Gilbert's syndrome.
D'Angelo R; Rinaldi C; Donato L; Nicocia G; Sidoti A
Ann Clin Lab Sci; 2015; 45(2):202-5. PubMed ID: 25887876
[TBL] [Abstract][Full Text] [Related]
11. Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan.
Cecchin E; Innocenti F; D'Andrea M; Corona G; De Mattia E; Biason P; Buonadonna A; Toffoli G
J Clin Oncol; 2009 May; 27(15):2457-65. PubMed ID: 19364970
[TBL] [Abstract][Full Text] [Related]
12. [A study of polymorphism in UDP-glucuronosyltransferase 1 (UGT-1A1) promoter gene in Korean patients with Gilbert's syndrome].
Kim YH; Yeon JE; Jung GM; Kim HJ; Kim JS; Byun KS; Bak YT; Lee CH
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):132-8. PubMed ID: 12499798
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis.
Ando Y; Saka H; Ando M; Sawa T; Muro K; Ueoka H; Yokoyama A; Saitoh S; Shimokata K; Hasegawa Y
Cancer Res; 2000 Dec; 60(24):6921-6. PubMed ID: 11156391
[TBL] [Abstract][Full Text] [Related]
14. Effect of UDP-glucuronosyltransferase 1A1 activity on risk for developing Gilbert's syndrome.
Huang MJ; Chen YC; Huang YY; Yang SS; Chen PL; Huang CS
Kaohsiung J Med Sci; 2019 Jul; 35(7):432-439. PubMed ID: 31017737
[TBL] [Abstract][Full Text] [Related]
15. A novel system for predicting the toxicity of irinotecan based on statistical pattern recognition with UGT1A genotypes.
Tsunedomi R; Hazama S; Fujita Y; Okayama N; Kanekiyo S; Inoue Y; Yoshino S; Yamasaki T; Suehiro Y; Oba K; Mishima H; Sakamoto J; Hamamoto Y; Oka M
Int J Oncol; 2014 Oct; 45(4):1381-90. PubMed ID: 25175642
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of Gilbert's syndrome.
Strassburg CP
Pharmacogenomics; 2008 Jun; 9(6):703-15. PubMed ID: 18518849
[TBL] [Abstract][Full Text] [Related]
17. Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis.
Liu D; Li J; Gao J; Li Y; Yang R; Shen L
BMC Cancer; 2017 Jun; 17(1):437. PubMed ID: 28637434
[TBL] [Abstract][Full Text] [Related]
18. UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.
Carlini LE; Meropol NJ; Bever J; Andria ML; Hill T; Gold P; Rogatko A; Wang H; Blanchard RL
Clin Cancer Res; 2005 Feb; 11(3):1226-36. PubMed ID: 15709193
[TBL] [Abstract][Full Text] [Related]
19. Refining the UGT1A haplotype associated with irinotecan-induced hematological toxicity in metastatic colorectal cancer patients treated with 5-fluorouracil/irinotecan-based regimens.
Lévesque E; Bélanger AS; Harvey M; Couture F; Jonker D; Innocenti F; Cecchin E; Toffoli G; Guillemette C
J Pharmacol Exp Ther; 2013 Apr; 345(1):95-101. PubMed ID: 23386248
[TBL] [Abstract][Full Text] [Related]
20. UGT1A1, UGT1A6 and UGT1A7 genetic analysis: repercussion for irinotecan pharmacogenetics in the São Miguel Island Population (Azores, Portugal).
Pacheco PR; Brilhante MJ; Ballart C; Sigalat F; Polena H; Cabral R; Branco CC; Mota-Vieira L
Mol Diagn Ther; 2009; 13(4):261-8. PubMed ID: 19712005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
